Welcome to our dedicated page for UFP Technologies news (Ticker: UFPT), a resource for investors and traders seeking the latest updates and insights on UFP Technologies stock.
UFP Technologies Inc. reports developments for a contract development and manufacturing organization focused on single-use and single-patient medical devices. Company news commonly covers quarterly and annual results, non-GAAP measures such as adjusted EBITDA and adjusted EPS, program ramps, backlog commentary, acquisition integration, and manufacturing capacity tied to medical-device customers.
Updates also include customer supply agreements, new program launches, investor conference participation, and governance matters such as executive succession planning. The company's products and components are used across medical device, wound care, infection prevention, minimally invasive surgery, wearable, orthopedic soft-goods, and orthopedic implant-packaging applications.
UFP Technologies (Nasdaq: UFPT) announced that President and CEO Mitchell Rock and Sr. Vice President, Treasurer and CFO Ron Lataille will present and host 1-on-1 investor meetings at the 17th Annual Midwest IDEAS Investor Conference on Wednesday, August 26, 2026, at The InterContinental in Chicago, IL.
The company’s presentation is scheduled for 8:35 AM CT and will be webcast via the conference website and the investor relations section of UFP Technologies’ website. The IDEAS conferences are investor-sponsored events produced by Three Part Advisors and feature institutional sponsors with more than $200 billion in assets under management.
UFP Technologies (Nasdaq: UFPT) reported record Q2 2026 results, with net income of $20.9 million, up 21.4% from $17.2 million in Q2 2025, and net sales of $174.0 million, up 15.1%. GAAP and adjusted diluted EPS were $2.68 and $2.92, respectively, both quarterly records.
For the first half of 2026, net income rose to $38.3 million from $34.4 million, on sales of $328.2 million versus $299.3 million. Gross margin improved to 29.3% in Q2. Adjusted EBITDA increased 14.3% in Q2 to $36.4 million and 8.5% year-to-date to $67.3 million. SG&A rose faster than sales, and adjusted SG&A as a percentage of sales increased year-over-year.
UFP Technologies (Nasdaq: UFPT) will report its second quarter 2026 financial results on Monday, August 3, 2026, after the U.S. stock market close. The company will host a conference call to discuss the results on Tuesday, August 4, 2026 at 8:30 AM Eastern Time, accessible via toll-free and international dial-in numbers and a live webcast, with a replay available on its investor relations website.
UFP Technologies (Nasdaq: UFPT) announced that President and CEO Mitchell Rock and Sr. Vice President, Treasurer and CFO Ron Lataille will present and host 1x1 investor meetings at the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026, in White Plains, NY.
UFP Technologies (Nasdaq: UFPT) announced that CEO Mitchell Rock and CFO Ron Lataille will present at the 16th Annual East Coast IDEAS Investor Conference on June 10, 2026 at The Westin Times Square in New York.
The presentation begins at 7:55 AM ET and will be available via webcast on both the conference website and UFP Technologies' investor relations page.
UFP Technologies (Nasdaq: UFPT) appointed Ryan Stafford as General Counsel and Senior Vice President of Human Resources, effective June 4, 2026, succeeding retiring executive Chris Litterio.
Stafford brings nearly three decades of senior legal, HR, and M&A leadership from roles at Littelfuse, Tyco International, and other organizations.
UFP Technologies (Nasdaq: UFPT) reported Q1 2026 net income of $17.5M and net sales of $154.2M, increases of 1.8% and 4.1% year-over-year. GAAP EPS was $2.24 and adjusted EPS was $2.48. Medical sales rose 5.9% while non-medical sales fell 15%.
Adjusted EBITDA was $31.0M. Company cited new Dominican Republic facilities in Q2 to expand capacity and noted start-up and labor inefficiency costs weighed on EPS growth.
UFP Technologies (Nasdaq: UFPT) will report first quarter 2026 financial results on Monday, May 4, 2026 after market close. A conference call to discuss results is scheduled for Tuesday, May 5, 2026 at 8:30 AM Eastern.
Dial-in numbers, a live webcast, and a replay will be available on the company’s Investor Relations website at https://ufpt.com/investors/.
UFP Technologies (Nasdaq: UFPT) announced that President Mitchell Rock and CFO Ron Lataille will participate in a virtual fireside chat and host 1x1 investor meetings at the KeyBanc Capital Markets Virtual Healthcare Forum on March 18, 2026, beginning at about 10:30 AM ET.
The company is presenting to investors and making management available for one-on-one meetings during the forum.
UFP Technologies (Nasdaq: UFPT) will present and host 1x1 investor meetings at the Raymond James 47th Annual Institutional Investors Conference in Orlando, March 1-4, 2026. Chairman & CEO R. Jeffrey Bailly and CFO Ron Lataille will present on March 3, 2026 at 2:50 PM ET. A live webcast of the presentation will be available.